Key Market Indicators
Spanish Antidepressant Medicine Sales are projected to decline to approximately $627 million by 2028 from around $680 million in 2023. This represents an average annual decrease of 1.3%. Despite this upcoming decline, the Spanish market has experienced an average annual growth of 1.8% since 2009. In 2023, Spain ranked as the second-largest market for antidepressant medicine sales globally, trailing just behind Germany, which led with sales of about $680 million. Following Spain, Italy and Australia secured the third and fourth positions, respectively.
